来自国际团队的研究人员揭示了BRCA2缺失导致PARP抑制剂(PARPi)敏感性的分子机制。研究发现BRCA2通过阻止PARP1在DNA损伤位点的异常滞留，保护RAD51丝免受PARPi干扰，阐明了"合成致死"效应的关键环节，为BRCA2突变肿瘤的靶向治疗提供新见解。 肿瘤抑制蛋白BRCA2在DNA同源 ...

A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.

RAD51 is a protein involved in homologous recombination repair (HRR) alterations. Developed in-house by Serra's laboratory, the RAD51 assay is based on the detection of this protein as a ...

Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...

RAD51 (a protein that helps repair damaged DNA), and PARP1 proteins involved in the DNA repair. The primary job of BRCA2 is to regulate RAD51, a key player in the accurate recombination of DNA ...